• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Agios Pharmaceuticals, Inc. (AGIO)

    -NasdaqGS
    107.73 Up 1.04(0.97%) Apr 17, 4:00PM EDT
    |After Hours : 108.11 Up 0.38 (0.35%) Apr 17, 7:58PM EDT
    Add to Portfolio
    Prev Close:106.69
    Open:105.90
    Bid:108.11 x 100
    Ask:N/A
    1y Target Est:120.00
    Beta:1.979
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:104.93 - 107.99
    52wk Range:31.51 - 138.85
    Volume:3,202,493
    Avg Vol (3m):656,661
    Market Cap:4.01B
    P/E (ttm):N/A
    EPS (ttm):-1.59
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    AGIOUp 0.97%4.01B
    ALXNDown 1.60%36.66B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):60.75
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.90
    Quarterly EPS Est (Mar-15) :-0.93
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Agios Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics in the field of cancer metabolism and rare genetic disorders of metabolism in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback